Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons

被引:373
作者
Gilley, Jonathan [1 ]
Coleman, Michael P. [1 ]
机构
[1] Babraham Inst, Cambridge, England
来源
PLOS BIOLOGY | 2010年 / 8卷 / 01期
基金
英国医学研究理事会;
关键词
WALLERIAN DEGENERATION WLD(S); NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; PROGRAMMED CELL-DEATH; SYMPATHETIC NEURONS; IN-VIVO; ADENINE-DINUCLEOTIDE; ENZYMATIC-ACTIVITY; NEURITE OUTGROWTH; PROTEIN-SYNTHESIS; NAD BIOSYNTHESIS;
D O I
10.1371/journal.pbio.1000300
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular triggers for axon degeneration remain unknown. We identify endogenous Nmnat2 as a labile axon survival factor whose constant replenishment by anterograde axonal transport is a limiting factor for axon survival. Specific depletion of Nmnat2 is sufficient to induce Wallerian-like degeneration of uninjured axons which endogenous Nmnat1 and Nmnat3 cannot prevent. Nmnat2 is by far the most labile Nmnat isoform and is depleted in distal stumps of injured neurites before Wallerian degeneration begins. Nmnat2 turnover is equally rapid in injured Wld(S) neurites, despite delayed neurite degeneration, showing it is not a consequence of degeneration and also that Wld(S) does not stabilize Nmnat2. Depletion of Nmnat2 below a threshold level is necessary for axon degeneration since exogenous Nmnat2 can protect injured neurites when expressed at high enough levels to overcome its short half-life. Furthermore, proteasome inhibition slows both Nmnat2 turnover and neurite degeneration. We conclude that endogenous Nmnat2 prevents spontaneous degeneration of healthy axons and propose that, when present, the more long-lived, functionally related Wld(S) protein substitutes for Nmnat2 loss after axon injury. Endogenous Nmnat2 represents an exciting new therapeutic target for axonal disorders.
引用
收藏
页数:18
相关论文
共 56 条
[1]   A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses [J].
Adalbert, R ;
Gillingwater, TH ;
Haley, JE ;
Bridge, K ;
Beirowski, B ;
Berek, L ;
Wagner, D ;
Grumme, D ;
Thomson, D ;
Celik, A ;
Addicks, K ;
Ribchester, RR ;
Coleman, MP .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (01) :271-277
[2]   Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration [J].
Araki, T ;
Sasaki, Y ;
Milbrandt, J .
SCIENCE, 2004, 305 (5686) :1010-1013
[3]   WldS requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration [J].
Avery, Michelle A. ;
Sheehan, Amy E. ;
Kerr, Kimberly S. ;
Wang, Jing ;
Freeman, Marc R. .
JOURNAL OF CELL BIOLOGY, 2009, 184 (04) :501-513
[4]   Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice [J].
Beirowski, B ;
Berek, L ;
Adalbert, R ;
Wagner, D ;
Grumme, DS ;
Addicks, K ;
Ribchester, RR ;
Coleman, MP .
JOURNAL OF NEUROSCIENCE METHODS, 2004, 134 (01) :23-35
[5]   The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves -: art. no. 6 [J].
Beirowski, B ;
Adalbert, R ;
Wagner, D ;
Grumme, DS ;
Addicks, K ;
Ribchester, RR ;
Coleman, MP .
BMC NEUROSCIENCE, 2005, 6 (1)
[6]   Non-Nuclear WldS Determines Its Neuroprotective Efficacy for Axons and Synapses In Vivo [J].
Beirowski, Bogdan ;
Babetto, Elisabetta ;
Gilley, Jon ;
Mazzola, Francesca ;
Conforti, Laura ;
Janeckova, Lucie ;
Magni, Giulio ;
Ribchester, Richard R. ;
Coleman, Michael P. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (03) :653-668
[7]   Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity [J].
Bendotti, C ;
Calvaresi, N ;
Chiveri, L ;
Prelle, A ;
Moggio, M ;
Braga, M ;
Silani, V ;
De Biasi, S .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 191 (1-2) :25-33
[8]   Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms [J].
Berger, F ;
Lau, C ;
Dahlmann, M ;
Ziegler, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (43) :36334-36341
[9]  
Burne JF, 1996, J NEUROSCI, V16, P2064
[10]  
CAMPENOT RB, 1992, PROTOCOLS NEURAL CEL, P53